101 related articles for article (PubMed ID: 22706820)
1. Vitamin D therapy and cardiac function in chronic kidney disease.
Rajagopalan S; Chan CT
JAMA; 2012 Jun; 307(21):2253; author reply 2254. PubMed ID: 22706820
[No Abstract] [Full Text] [Related]
2. Vitamin D therapy and cardiac function in chronic kidney disease.
Slatopolsky E
JAMA; 2012 Jun; 307(21):2254; author reply 2254-5. PubMed ID: 22706822
[No Abstract] [Full Text] [Related]
3. Vitamin D therapy and cardiac function in chronic kidney disease.
Fourtounas C
JAMA; 2012 Jun; 307(21):2253; author reply 2254. PubMed ID: 22706819
[No Abstract] [Full Text] [Related]
4. Vitamin D in chronic kidney disease: more questions than answers.
Anker SD; von Haehling S
JAMA; 2012 Feb; 307(7):722-3. PubMed ID: 22337683
[No Abstract] [Full Text] [Related]
5. Questioning the validity of a recent randomized trial on paricalcitol in patients with echocardiographic evidence of cardiac hypertrophy.
Fedele F; Frati G; Biondi-Zoccai G
Int J Cardiol; 2013 Sep; 167(5):2343-4. PubMed ID: 23176772
[No Abstract] [Full Text] [Related]
6. Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial.
Thadhani R; Appelbaum E; Pritchett Y; Chang Y; Wenger J; Tamez H; Bhan I; Agarwal R; Zoccali C; Wanner C; Lloyd-Jones D; Cannata J; Thompson BT; Andress D; Zhang W; Packham D; Singh B; Zehnder D; Shah A; Pachika A; Manning WJ; Solomon SD
JAMA; 2012 Feb; 307(7):674-84. PubMed ID: 22337679
[TBL] [Abstract][Full Text] [Related]
7. Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters.
Matias PJ; Jorge C; Ferreira C; Borges M; Aires I; Amaral T; Gil C; Cortez J; Ferreira A
Clin J Am Soc Nephrol; 2010 May; 5(5):905-11. PubMed ID: 20203163
[TBL] [Abstract][Full Text] [Related]
8. The effects of vitamin D therapy on left ventricular structure and function - are these the underlying explanations for improved CKD patient survival?
Covic A; Voroneanu L; Goldsmith D
Nephron Clin Pract; 2010; 116(3):c187-95. PubMed ID: 20606478
[TBL] [Abstract][Full Text] [Related]
9. Ergocalciferol supplementation in children with CKD delays the onset of secondary hyperparathyroidism: a randomized trial.
Shroff R; Wan M; Gullett A; Ledermann S; Shute R; Knott C; Wells D; Aitkenhead H; Manickavasagar B; van't Hoff W; Rees L
Clin J Am Soc Nephrol; 2012 Feb; 7(2):216-23. PubMed ID: 22266572
[TBL] [Abstract][Full Text] [Related]
10. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease.
Zisman AL; Hristova M; Ho LT; Sprague SM
Am J Nephrol; 2007; 27(1):36-43. PubMed ID: 17215573
[TBL] [Abstract][Full Text] [Related]
11. A double-blind, randomized, placebo-controlled trial of combined calcitriol and ergocalciferol versus ergocalciferol alone in chronic kidney disease with proteinuria.
Susantitaphong P; Nakwan S; Peerapornratana S; Tiranathanagul K; Katavetin P; Srisawat N; Praditpornsilpa K; Eiam-Ong S
BMC Nephrol; 2017 Jan; 18(1):19. PubMed ID: 28088187
[TBL] [Abstract][Full Text] [Related]
12. [Vitamin D2 or vitamin D3?].
Mistretta VI; Delanaye P; Chapelle JP; Souberbielle JC; Cavalier E
Rev Med Interne; 2008 Oct; 29(10):815-20. PubMed ID: 18406498
[TBL] [Abstract][Full Text] [Related]
13. Effect of high-dose oral cholecalciferol on cardiac mechanics in children with chronic kidney disease.
Deveci M; Aytaç MB; Altun G; Kayabey Ö; Babaoğlu K
Cardiol Young; 2017 Nov; 27(9):1807-1814. PubMed ID: 28770692
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease.
Tamez H; Zoccali C; Packham D; Wenger J; Bhan I; Appelbaum E; Pritchett Y; Chang Y; Agarwal R; Wanner C; Lloyd-Jones D; Cannata J; Thompson BT; Andress D; Zhang W; Singh B; Zehnder D; Pachika A; Manning WJ; Shah A; Solomon SD; Thadhani R
Am Heart J; 2012 Dec; 164(6):902-9.e2. PubMed ID: 23194491
[TBL] [Abstract][Full Text] [Related]
15. Doxercalciferol, a pro-hormone of vitamin D, prevents the development of cardiac hypertrophy in rats.
Choi JH; Ke Q; Bae S; Lee JY; Kim YJ; Kim UK; Arbeeny C; Thadhani R; Kang PM
J Card Fail; 2011 Dec; 17(12):1051-8. PubMed ID: 22123370
[TBL] [Abstract][Full Text] [Related]
16. The use of group sequential, information-based sample size re-estimation in the design of the PRIMO study of chronic kidney disease.
Pritchett Y; Jemiai Y; Chang Y; Bhan I; Agarwal R; Zoccali C; Wanner C; Lloyd-Jones D; Cannata-Andía JB; Thompson T; Appelbaum E; Audhya P; Andress D; Zhang W; Solomon S; Manning WJ; Thadhani R
Clin Trials; 2011 Apr; 8(2):165-74. PubMed ID: 21478328
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D2 versus vitamin D3 supplementation in hemodialysis patients: a comparative pilot study.
Daroux M; Shenouda M; Bacri JL; Lemaitre V; Vanhille P; Bataille P
J Nephrol; 2013; 26(1):152-7. PubMed ID: 22641581
[TBL] [Abstract][Full Text] [Related]
18. A single high dose of ergocalciferol can be used to boost 25-hydroxyvitamin D levels in children with kidney disease.
Belostotsky V; Mughal Z; Webb NJ
Pediatr Nephrol; 2009 Mar; 24(3):625-6. PubMed ID: 19048303
[No Abstract] [Full Text] [Related]
19. Vitamin D deficiency: appropriate replenishment therapies and the effects of vitamin D toxicity.
Carlton S; Clopton D; Cappuzzo KA
Consult Pharm; 2010 Mar; 25(3):171-7. PubMed ID: 20363711
[TBL] [Abstract][Full Text] [Related]
20. Effect of high dose ergocalciferol in chronic kidney disease patients with 25-hydroxyvitamin D deficiency.
Trakarnvanich T; Chalapipat O; Disthabanchong S; Kurathong S; Praditpornsilpa K; Stitchantrakul W; Chailurkit LO
J Med Assoc Thai; 2010 Aug; 93(8):885-91. PubMed ID: 20718162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
